MedPath

CSIRO (COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION)

🇦🇺Australia
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

26

Active:2
Completed:9

Trial Phases

2 Phases

Phase 3:1
Not Applicable:20

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (21 trials with phase data)• Click on a phase to view related trials

Not Applicable
20 (95.2%)
Phase 3
1 (4.8%)
No trials found

News

Australian-First "Seek-and-Destroy" Cancer Therapy Begins Human Trials Targeting CDCP1 Protein

A groundbreaking radioactive therapy targeting the CDCP1 protein in cancer cells has begun its first human trial in Australia, with a 69-year-old Brisbane woman becoming the first patient to receive the treatment.

First Nanobody Treatment Shows Promise Against Deadly Nipah and Hendra Viruses

University of Queensland researchers have identified DS90, the first nanobody capable of neutralizing both Nipah and Hendra viruses, for which no approved vaccines or cures currently exist.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.